Skip to main content
SEER
NASDAQ Industrial Applications And Services

Activist Group Lobs Fourth, Highest Buyout Bid for Seer at $2.55/Share, a 51% Premium

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$2.015
Mkt Cap
$111.462M
52W Low
$1.55
52W High
$2.41
52W Position info
30% above low
Off High info
16% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

SEER sits 30% above its 52-week low of $1.55 on elevated volume (2.0× avg).

Summary

Activist investor Radoff-JEC Group has submitted an improved, non-binding proposal to acquire Seer for $2.55 per share in cash plus a contingent value right, a 51% premium to the unaffected price, intensifying the proxy fight and buyout contest.


Key Events · M&A and Partnerships · SEER

  • Improved Buyout Proposal at $2.55/Share

    Radoff-JEC Group submitted a fourth, non-binding proposal to acquire all outstanding shares for $2.55 per share in cash, a 51% premium to the unaffected price and 29% premium to the current price.

  • Contingent Value Right for Asset Sales

    The proposal includes a CVR entitling stockholders to 85% of net proceeds from any license, sale, or disposition of Seer's business and assets, including PrognomiQ, with payments targeted within 6-12 months post-acquisition.

  • Offer Expires August 10, 2026

    The proposal is not subject to financing conditions and expires on August 10, 2026, urging the special committee to engage immediately.

  • Activist Escalates Proxy Contest

    This move intensifies the ongoing proxy battle, where all three proxy advisors have already recommended the activist slate, and follows the board's rejection of the CEO's $2.45/share buyout offer.


Analysis · SEER · Industrial Applications And Services

The Radoff-JEC Group, which holds a 7.7% stake in Seer, has delivered its fourth and richest buyout proposal yet: $2.55 per share in cash plus a contingent value right. The offer commands a 51% premium to the unaffected share price and a 29% premium to the current price, squarely challenging the board's earlier rejection of the CEO's $2.45/share bid. Under the CVR, stockholders would receive 85% of net proceeds from any sale of Seer's assets—including PrognomiQ—within 6–12 months. With no financing conditions and an August 10, 2026 expiration, the proposal puts immediate pressure on the special committee to engage. This latest salvo escalates the ongoing proxy contest and buyout battle, where all three proxy advisors have already thrown their weight behind the activist slate.

At the time of this filing, SEER was trading at $2.02 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $111.5M. The 52-week trading range was $1.55 to $2.41. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SEER - Latest Insights

SEER
Jul 28, 2026, 12:47 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.03
Real-time Price: $2.02 info
Change: -$0.0100 (-0.49%) info
Market Cap: $111.462M info
SEER
Jul 23, 2026, 6:25 PM EDT
Filing Type: DFAN14A
Importance Score:
9
Price at Filing: $2.04
Real-time Price: $2.02 info
Change: -$0.025 (-1%) info
Market Cap: $111.462M info
SEER
Jul 22, 2026, 9:10 AM EDT
Filing Type: DFAN14A
Importance Score:
9
Price at Filing: $2.02
Real-time Price: $2.02 info
Change: -$0.0068 (-0.34%) info
Market Cap: $111.462M info
SEER
Jul 20, 2026, 4:10 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $2.04
Real-time Price: $2.02 info
Change: -$0.025 (-1%) info
Market Cap: $111.462M info
SEER
Jul 20, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.04
Real-time Price: $2.02 info
Change: -$0.025 (-1%) info
Market Cap: $111.462M info